Cytotoxic chemotherapy for incurable colorectal cancer: living with a PICC-line by Molloy, D. et al.
  
 
 
 
 
 
Molloy, D. and Smith, L.N. and Aitchison, T. (2008) Cytotoxic 
chemotherapy for incurable colorectal cancer: living with a PICC-line. 
Journal of Clinical Nursing, 17 (18). pp. 2398-2407. ISSN 0962-1067 
 
 
 
http://eprints.gla.ac.uk/4915/ 
 
Deposited on: 9 February 2009 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
Cytotoxic chemotherapy for incurable colorectal 
cancer: living with a PICC-line 
 
 
 
 
 
 
 
 
 
 
Doreen Molloy MSc, BA, PGCT LHE, RGN 
Lecturer 
 
Lorraine N Smith PhD, MEd, BScN 
Professor of Nursing 
University of Glasgow 
 
Tom Aitchison 
Senior Lecturer, Department of Statistics 
University of Glasgow  
 
No of words: 5,525 excluding tables 
All correspondence to: 
Professor Lorraine N Smith  
Nursing & Health Care 
University of Glasgow 
59 Oakfield Avenue 
Glasgow, UK 
G12 8LW 
 
Tel: 00 44 141 330 5498 
Email: l.n.smith@clinmed.gla.ac.uk 
 
 
 
 
 
Abstract 
 
Title.  
Cytotoxic chemotherapy for incurable colorectal cancer: living with a PICC-line 
 
Objectives. 
1. To determine which aspects of living with a peripherally inserted central catheter (PICC) 
line cause Modified de Gramont (MdG) patients most difficulty. 
2. To explore MdG patients’ views of the PICC-line experience. 
3. To determine if patients view PICC-lines as a benefit or a burden when receiving 
ambulatory MdG chemotherapy. 
 
Design. 
A two-stage, descriptive study.  Phase 1 comprised semi-structured interviews.  Phase 2 
surveyed the MdG population.  Phase 1 interview data informed the Phase 2 questionnaire.   
 
Setting. 
West of Scotland Cancer Care Centre. 
 
Sample. 
Phase 1, a convenience sample of 10 MdG patients; Phase 2, 62 consecutive patients.  
 
Findings and results. 
A response rate of 93.9% for Phase 2. The majority of PICC-line patients held favourable 
views towards having a PICC- line and adapted well with minimal disruption to daily life.  
Concerns evident regarding coping at home with a PICC- line, chemotherapy spillage, dealing 
with complex information and the responsibility of patients/carers regarding PICC-line 
management.  Patients preferred ambulatory chemotherapy to in-patient treatment. 
 
Conclusions. 
PICC-lines should be considered for more chemotherapy patients but that service 
development necessary to ensure individual needs addressed.  
 
Relevance to Clinical Practice. 
• Contributes to the PICC-line literature by providing a national patient perspective on a 
range of daily living activities 
 
• PICC-line patients prefer out-patient ambulatory chemotherapy rather than in-patient 
treatment 
• the longer a patient has a PICC-line, the more able they are to manage activities such as 
dressing. 
• Highlights concerns remain over chemotherapy spillage, partner/carer responsibility for 
PICC-line maintenance and the proper balance between required information and what the 
patient wants to know. 
 
Key words: 
Ambulatory chemotherapy, PICC-line, peripherally inserted central catheter, patient, 
information, adaptation, coping 
 
Introduction  
Restructuring of cancer services in the United Kingdom (UK) has been necessary to cope 
with the growing demand for chemotherapy (Twelves 2001), with the majority of patients 
now receiving chemotherapy in the out-patient setting (Young and Kerr 2001).  Ambulatory 
care, that is the delivery of treatment in the patient’s home, is the fastest growing health-care 
service delivery model in industrialised nations (AETMIS 2004).  
 
Insertion of a central venous access device (CVAD) such as a Peripherally Inserted Central 
Catheter (PICC-line) is necessary before infusional therapy can be given safely in the 
ambulatory setting (SEHD 2000).  PICC-lines are a cost-effective way of safely administering 
chemotherapy in the ambulatory setting (Galloway 2002) and reduce the need for peripheral 
venous cannulation (Gabriel 2003, 2000).  Although no European data could be found 
detailing numbers of PICC-lines used, Moureau et al (2002) reported that >50% of American 
patients undergoing ambulatory therapy had a PICC-line in situ.   
 
Nevertheless ambulatory chemotherapy is laden with challenges (AETMIS 2004) as patients 
are more likely to experience difficulties or side effects at home without expert help close to 
hand (marc 2005, McCaughan & Thompson 2000).  The insertion and ongoing maintenance 
of PICC-lines can have a considerable impact on patients’ lives, not all of whom can be 
assumed to have the physical and cognitive ability to cope with these additional demands 
(AETMIS 2004, Dobson 2001).  Difficulties in bathing, sleeping and dressing are reported 
(Oakley et al 2000) although the impact on daily life is minimal (Gabriel 2003, 2000).  
However a lack of evidence exists to support many of the assumptions regarding ambulatory 
chemotherapy, for example that it improves quality of life (Borras et al 2001).  
 
Little has been published regarding how chemotherapy patients cope with their devices and 
the impact PICC-lines and other CVADs have upon their lives.  Most PICC-line literature 
concentrates on medical-technical or educational aspects (Collins 2004, Philpot and Griffiths 
2003, Carlson 1999) with a dearth of UK-based literature on patients’ needs whilst 
undergoing ambulatory chemotherapy with a PICC-line in situ.   
 
Many patients remain dissatisfied with the information given to them concerning their cancer 
diagnosis and chemotherapy treatment (Skalla et al 2004, Kruijver et al 2000, Jenkins et al 
2001, Elf & Wikblad 2001, Sitzia & Wood 1998); and feel unprepared particularly in the face 
of increasingly complex chemotherapy regimens (McCaughan and Thomson 2000).  This 
study examined the views and experiences of patients receiving one of the most commonly 
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used PICC-line ambulatory chemotherapy regimens, the Modified de Gramont (MdG) 
regimen.   
 
Infusion Regime in the Study Site 
The MdG regimen is used to treat patients with incurable colorectal cancer and provides dose 
intensive exposure to 5-FU every two weeks (Leonard et al 2002).  The cytotoxic agent 5-
Fluorouracil (5-FU) has been the mainstay of chemotherapy for colorectal cancer for more 
than 20 years (Leonard et al 2002) and both the National Institute for Health and Clinical 
Excellence (NICE 2005) and the Scottish Intercollegiate Guidelines Network (SIGN 2003) 
recommend ‘5-FU containing’ regimens as first line treatment in colorectal cancer.  Response 
to 5-FU in advanced colorectal cancer is increased by the concomitant administration of 
folinic acid (FA) (Leonard et al 2002, de Gramont et al 1998).  
 
In the study site, patients receiving MdG have a PICC-line inserted in the week prior to 
chemotherapy commencement.  Patients attend the unit on Day 1 of the regimen when FA is 
given as a two-hour infusion followed by a bolus of 5-FU.  Patients then go home with a 46-
hour, 5-FU infusion pump attached to the PICC-line which is disconnected by the community 
nurse on completion of the infusion.  The sequence is repeated until completion of treatment. 
 
Research Objectives 
1. To determine which aspects of living with a PICC-line cause MdG [Modified de Gramont] 
patients most difficulty. 
2.  To explore MdG patients’ views of the PICC-line experience. 
3. To determine if patients view PICC-lines as a benefit or a burden when receiving 
ambulatory MdG chemotherapy. 
 
Methods 
 
Study design  
This was a two-stage, descriptive study.  Phase 1 comprised semi-structured interviews with a 
convenience sample of MdG patients and Phase 2 was a questionnaire survey of the MdG 
study site population.  Phase 1 interview data informed the Phase 2 questionnaire.  Phase 1 
patients were excluded from Phase 2.  Data were collected 2004-06.   
 
Ethics Approval 
Ethics approval was sought and given on two separate occasions given the phased study 
design.  As study participants were receiving cytotoxic chemotherapy for incurable colon 
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cancer, they were considered to be a vulnerable population.  All information was treated 
confidentially and in accordance with the Data Protection Act (1998).  Having provided 
informed consent, no patient withdrew from the study. 
 
Study setting and population 
The study was conducted at the chemotherapy day unit (CDU) of the West of Scotland 
Cancer Care Centre where approximately 250 patients with incurable colorectal cancer are 
treated with ambulatory MdG chemotherapy via a PICC-line annually.  It was decided in line 
with the research questions, that study participants must be at least eight weeks into their 
chemotherapy regime to allow a reasonable period for patients to have experienced living 
with a PICC-line.  Exclusion criteria were designed to avoid over-burdening sick patients and 
we employed the usual, standard assessment tools of the CDU assessment unit.   
 
Study inclusion criteria were: 
• incurable colorectal cancer, 
• a PICC-line in situ for >7 weeks, 
• 18 years of age, ≥
• attending the chemotherapy day unit at the study site, 
• read and write English 
• receiving any MdG chemotherapy regimen. 
 
Exclusion criteria were patients with: 
• >grade two chemotherapy-associated toxicities using CDU assessment criteria,  
• WHO (1979) Performance Status (PS) of >2. 
 
A convenience sample of 10 patients was recruited from the CDU for Phase 1 interviews.  In 
Phase 2, 69 consecutive patients meeting the eligibility criteria were approached for study 
participation.  On statistical advice, by including all eligible patients as potential participants, 
it was considered that the sample would be representative of the target population providing 
there were minimal non-responders. 
 
Data collection tools 
The Phase 1 semi-structured interview schedule consisted of 9 prompts that asked  
interviewees about their PICC-line experience.  Four themes emerged from the data which 
used to develop the Phase 2 questionnaire. 
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There were 5 sections in the questionnaire: demographics [sex, age, distance from the CDU, 
ease of travelling to the CDU, number of PICC-lines inserted, length of time PICC-line in situ 
on completion of questionnaire]; impact on daily life; responsibility/coping at home; 
information giving; and adaptation/acceptance.  Likert-type scales were chosen to report 
patient views (Oppenheim 1992).  For ‘impact on daily life’, possible responses were ‘about 
the same’, ‘a little more difficult’, ‘a lot more difficult’ and ‘can’t do because of the PICC-
line’.  A ‘not applicable’ response allowed participants to indicate any activities not carried 
out before PICC-line insertion.  For the sections entitled ‘responsibility/coping at home’, 
‘information giving’ and ‘adaptation/acceptance’, possible responses were ‘agree’, ‘strongly 
agree’, ‘neither agree nor disagree’, ‘disagree’ and ‘strongly disagree’.  A neutral position 
was included (Priest et al 1995).  A final, free-text section invited participants to add anything 
relevant not covered elsewhere. 
 
Pilot Studies: Phases 1 and 2 
Following ethics approval, both the interview prompt schedule and questionnaire were piloted 
successfully in the same health board as the main study and participants excluded from the 
main study. Three pilot interviews using the semi-structured prompt schedule were 
audiotaped and transcribed and assessed positively for interviewing style, study feasibility 
and data quality.  The Phase 2 questionnaire was reviewed by an expert panel (Chemotherapy 
Clinical Nurse Specialist, Oncology Research Nurse, Cancer Nurse Consultant, Colorectal 
Clinical Nurse Specialist, Oncology Practice Development Nurse) who agreed that the 
questionnaire had face and content validity in that it was representative of the interview 
themes.  On pre-testing several small amendments were suggested to question wording and 
these were incorporated into the questionnaire design. 
 
Main Study 
 
Phase 1 Interview process and analysis 
Potential participants for Phase 1 were identified from the CDU admissions list and recruited 
by the researcher.  All participants elected to be interviewed during their next scheduled 
chemotherapy appointment.  All interviews took place in a quiet, non-clinical room adjacent 
to the CDU.  Immediately prior to each interview, the researcher assessed each participant’s 
toxicity grading and Performance Status (WHO 1979) to ensure they were sufficiently well to 
be interviewed.  All were satisfactory.  However, one interview was abandoned after 10 
minutes as the participant became ill and they were then omitted from the study.  Interviews 
varied from eight to 32 minutes, averaging 19 minutes and all were tape-recorded with 
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permission.  Field notes were completed immediately following the interview rather than 
during the interview (Holloway & Wheeler 2002).  Patients appeared to welcome the 
opportunity to discuss their chemotherapy treatment. 
 
Phase 1 data analysis 
Data analysis (Figure 1) occurred after completion of all interviews to minimise influencing 
ongoing interviews.  All were transcribed verbatim and read alongside field notes (Figure 1).  
Manifest content analysis was employed as common themes were being investigated rather 
than applying interpretive analysis; in other words ‘what was said’ was under investigation as 
opposed to ‘why something was said’ (Polit et al 2001).  Face and content validity were 
achieved as the identified themes were in line with previous work (Oakley et al 2000). 
 
Phase 2 questionnaire administration 
Recruitment was carried out by the researcher and took place in the CDU using the 
chemotherapy appointments list to determine when potential participants were attending the 
unit.   
 
A reply-paid envelope was provided and it was requested that the questionnaire be returned 
within two weeks.  However, the majority of participants (n=54) elected to complete the 
questionnaire whilst in the CDU, stating that it would help pass the time during chemotherapy 
administration.  Twelve participants completed the questionnaire at home with 8 completed 
questionnaires returned within two weeks.  A reminder letter was posted for the four non-
responders but they were not returned.  Ordinarily the PICC-line was in situ for 11 weeks 
(Range: 8-17) at questionnaire completion. 
 
Phase 2 data analysis 
Descriptive statistics were used with patient demographics.  Inferential statistics determined 
the views most likely to be held by the study sample and explored the areas where there was 
less consensus among respondents.  Following initial data analysis, the ‘agree and strongly 
agree’ ratings were aggregated as were ‘disagree and strongly disagree’ for ‘responsibility 
and coping at home’, ‘information giving’ and ‘adaptation/acceptance’ statements.  On 
statistical advice 95% confidence intervals were used to quantify the magnitude of population 
proportions and differences in such, for the views of the study sample. 
 
Findings: Phase 1 
Response rate 
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Of the 11 potential participants approached to take part in Phase 1, one declined.  Of the 10 
who agreed to be interviewed, one was unable to complete the interview giving a 90.0% (n=9) 
response rate.   
  
Demographics  
Participants’ ages ranged from 42-76 years of age.  Five interviewees were female.  The mean 
length of time participants had a PICC-line in situ was 13 weeks (Range: 9–23).  For the 
majority (n=7), this was their first experience of having a PICC-line and only two participants 
knew what a PICC-line was prior to requiring one.  The mean distance travelled by 
participants to receive treatment was 19 miles.   
 
Themes 
Overall four themes emerged; (i) the impact of the PICC-line on daily life; (ii) responsibility 
and coping at home; (iii) information giving; and (iv) adaptation/acceptance of the PICC-line. 
Each theme became the basis for a section of the questionnaire.   
 
Participants held both positive and negative views towards the PICC-line experience.  The 
main advantages reported were not requiring hospital admission, the reduced need for 
peripheral venous cannulation and the ease of chemotherapy administration.  Nonetheless life 
changed with a PICC-line and daily activities such as washing, dressing, sleeping and 
engaging in hobbies were affected.  As one said “having a bath, that was the worst 
bit…..you’ve got to hang your arm over the side and you can’t get a good wash with just one 
hand”. P2  Most adapted well but there were concerns; e.g. chemotherapy spillage, PICC-line 
malfunctioning and the PICC-line alerting outsiders to the participant’s illness.  There was 
unease around the expected level of involvement in terms of PICC-line.  For example “I 
wasn’t too happy about them asking her to get involved if there’s a problem with the line and 
I said ‘well wait a wee minute here. I am not putting that sort of responsibility on to my 
wife…is it going to turn into septicaemia or phlebitis or thrombosis because that’s the actual 
words they used…frightening names”. P4 
 
Information giving to PICC-line patients appeared to be the greatest challenge.  Although 
participants felt well supported by staff, they struggled with the volume and nature of the 
information.  Information was described as “unhelpful, excessive” and at times, “frightening.”  
Nevertheless, the advantages of having a PICC-line outweighed the disadvantages for most 
and the general consensus was of adaptation and acceptance.  “I know I’m dying…..but this 
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line (PICC) has meant that I’ve not needed to be away from the house overnight, leaving my 
own bed and that’s been great”. P10 
 
Results: Phase 2 
Response rate 
Of the 69 patients approached to take part in Phase 2, three refused.  Of the 66 who agreed to 
take part, 62 completed the questionnaire giving a response rate of 93.9%.   
 
Patient profile 
The ‘typical’ patient was male, aged 60-79 years, lived within 20 miles of the Chemotherapy 
Day Unit, found it easy to access the unit, did not know what a PICC-line was prior to 
insertion and usually had had only one PICC-line insertion for the current course of treatment 
(Table 1). 
 
Impact on daily life 
A majority of patients (Table 2) found showering (CI: 41%, 72%) and hair washing (CI: 44%, 
70%) ‘a lot more difficult’ with a PICC-line in situ.  However a sizeable minority of patients 
also found bathing (CI 30%, 58%) and sleeping (CI: 16%, 40%) problematic.  Nevertheless 
the majority of patients were able to maintain daily living activities (DLAs) satisfactorily. 
 
Responsibility/coping at home 
As noted earlier, the questionnaire presented respondents with a series of statements on 
responsibility and coping, information giving and acceptance. In response to each set of 
statements, the same data analysis procedure was employed; that is a 95% confidence interval 
[CI] was calculated between those who ‘agreed/strongly agreed’ with each statement and 
those who ‘disagreed/disagreed strongly’.  If the resulting CI was entirely positive, then a 
clear majority of patients ‘agreed’ with the statement.  If the CI was entirely negative, then a 
clear majority ‘disagreed’ with the statement.  This procedure allowed us to understand which 
statements had the unequivocal support [or not] of the majority of our PICC-line patients.   
 
There was strong evidence (Table 3) that our patients were much more likely to feel well-
supported during PICC-line treatment than not (CI: 83%, 100%); were happy to take 
responsibility for their PICC-line (CI: 26%, 66%); felt a PICC-line contributed to their 
maintaining independence (CI: 42%, 78%); that PICC-lines made chemotherapy easier to 
receive (CI: 55%, 83%); and were relaxed at home with a line (CI: 35%, 74%).  They also 
strongly preferred to receive out-patient treatment (CI: -91%, -63%). 
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However the positive benefits were tinged with some concerns.  For example, while a 
significantly larger population proportion was likely to deny that chemotherapy via a PICC-
line, presented extra worries (CI: 11%, 56%), equally there were acknowledged worries about 
potential chemotherapy spillage (CI: 33%, 76%), about the possible malfunction of their 
PICC-line (CI: 11%, 59%); and/or the dislodging of a PICC-line from situ (CI: 3%, 49%); and 
many patients felt their friends and families worried about the PICC-line (CI: 11%; 58%). 
 
Information giving  
Again, the same statistical procedure described earlier was applied to information statements.   
Table 4 shows that overall a significant majority of MdG PICC-line patients wanted as much 
information as possible about their situation (CI: 38%, 77%) and received optimal 
information (CI: 37%, 73%) but nonetheless many had difficulty remembering the 
information (CI: 32%, 74%) and some found it ‘scary’ (CI: 19%, 64%).  A small majority 
thought too much information was a ‘bad thing’ (CI: 0.03%, 45%).  
 
It was interesting to note patient views on doctors’ and nurses’ information giving (Table 4). 
Given that patients wanted to know as much about their situation as possible, we were 
somewhat surprised by the lack of a clear-cut position from patients about being told 
everything about their PICC-line.  Rather there were almost equal numbers ‘agreeing’ and 
‘disagreeing’ as well as those declaring no view at all (CI: -27%, 20%).  Ambivalence was 
also seen on the part of patients (CI: -26%, 23%) as to why nurses and doctors provide full 
information - ‘it is just because they feel they have to’.  While there were no statistical 
differences between patients who felt they had been given a choice to have a PICC-line and 
those who weren’t; or between those who knew what to expect from a PICC-line insertion 
and those who didn’t, it is striking that many patients felt unprepared (n=32) or felt they had 
been given little choice on the treatment mode (n=32). 
 
Adaptation/acceptance 
Table 5 provides strong evidence that a significant majority saw their PICC-line as 
beneficial with advantages outweighing disadvantages (CI: 72%, 92%); would 
recommend one to others (CI: 72%, 92%); and although more help was needed at the 
beginning (CI: 42%, 77%), adapted positively to the line (CI: 56%, 89%).  Only a 
minority found the experience frightening (CI: -56%, -11) and struggled to adapt to 
life with a PICC-line (CI: -68%, -25%).  However the degree of comfort patients felt 
about strangers knowing they had a PICC-line (CI: -42%, 6%) or in showing it to 
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others (CI: -19%, 29%) indicated again a considerable ambivalence with a sizeable 
minority thinking it best to avoid crowds with a PICC-line in situ (CI: -9%, 35%).   
 
Additional written comments were provided by 13 respondents but these tended to be 
idiosyncratic complaints around car parking or reiteration of the interviews’ thematic analysis 
and questionnaire results. 
 
Discussion 
 
Living with a PICC-line  
In this study, only minimal difficulty with most DLAs was reported by most patients in line 
with Gabriel (2003; 2000) who found that lifestyle was relatively unaffected by a PICC-line.  
Like Oakley et al (2000) who reported that patients experienced most difficulty with bathing 
and sleeping but that these diminished with time, the patients in this study experienced 
difficulties with showering, hair washing, bathing and sleeping.  These findings are important 
as they affect our sense of well-being and therefore it was clear that more, practical 
information related to bathing/showering and sleeping with a PICC-line was needed by these 
patients. 
 
Oakley et al (2000) also reported that half of their study patients experienced difficulty in 
dressing but this finding was not upheld in our study.  It may be that as the patients in this 
study had the PICC-line in situ for a mean of 11 weeks at questionnaire completion compared 
with the four weeks in Oakley et al’s study, that any initial difficulties with dressing were 
resolved with patients learning how to manage effectively over time. 
 
Responsibility for the PICC-line 
In this study, participants generally coped well at home with their PICC-lines and most 
appeared happy to take on the additional responsibility.  There was an acceptance that having 
a PICC-line had a major impact on their daily lives but the bonus was not being hospitalised 
to receive chemotherapy.  This is in keeping with Chernecky (2001) who found that the 
advantages associated with a CVAD in the home setting more than compensated for the 
difficulties.   
 
Most patients in this study felt well supported and able to cope at home with the PICC-line.  
Therefore despite their fears, generally patients were happy to take on the added 
responsibility associated with the PICC-line.  Furthermore, there was strong evidence that 
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patients did not want to be hospitalised for chemotherapy treatment which may have 
influenced their acceptance to take on the responsibility for the PICC-line.  However a desire 
to be treated away from the hospital setting does not necessarily imply a willingness or 
competence to take on board the added responsibility necessary.  This study showed that in 
keeping with AETMIS (2004), it could not be assumed that all patients had the confidence to 
cope at home with a PICC-line. 
 
Despite the positive views towards coping at home with a PICC-line, concerns continued 
related to chemotherapy spillage, malfunction of the PICC-line or the PICC-line falling out.  
Patients felt their families and friends worried about the PICC-line.  However when given the 
opportunity to provide additional comments in the questionnaire, nothing was said.  
Nevertheless friends and family may require some assistance to aid their coping. 
 
Information giving 
This study suggests participants found it difficult to cope with the amount of information 
given to them around the time of PICC-line insertion and some information was frightening 
and/or unhelpful.  This is not surprising when one considers the information these patients 
require in what could only be a stressful situation: e.g. details of cancer recurrence, prognostic 
outlook, schedule of appointments, chemotherapy regimen and side effect management and 
PICC-line information. 
 
Although the patients in this study reported a high information need, most also wished to 
avoid excessive information about what might go wrong.  In line with others who found 
patients felt unprepared for the insertion experience despite the information given pre-
insertion (Oakley et al 2000), the patients in this study also felt likewise.  This suggests that 
the type and timing of information is still not all it could be despite continuing interest in 
improving information quality (Skalla et al 2004, Elf & Wikblad 2001, McCaughan & 
Thompson 2000, Sitzia & Wood 1998).  New and more efficient ways of giving patients 
information that is complex and voluminous, are required if patients’ needs are to be 
adequately addressed. 
 
Adapting to the PICC-line 
The majority of participants adapted well to the experience of living with a PICC-line in 
keeping with earlier studies (Gabriel 2003, 2000, Oakley et al 2000) and stated that they 
would recommend a PICC-line to other patients.  The potential advantages associated with a 
PICC-line appeared critical in helping patients accept ambulatory chemotherapy.  
Questionnaire results showed that the majority feared needles but that the PICC-line with its 
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infusion pump made chemotherapy administration easier.  Indeed, the reduction in the 
number of venous cannulations for chemotherapy administration is one of the most prominent 
positive indicators for acceptance of a PICC-line or other CVADs (AETMIS 2004, Chernecky 
2001).  Many cancer patients require intensive and/or lengthy chemotherapy regimens using 
irritating agents that can irreparably damage peripheral venous access and may have or 
develop needle phobia (Ost 1992).  Therefore this advantage alone may merit the insertion of 
a PICC-line for some patients.  
 
It was also evident that despite initial difficulties, patients felt the benefits of a PICC-line 
outweighed the drawbacks.  But more help was required at the start of the PICC-line 
experience which again has implications for the support of PICC-line patients.   
 
Our findings on what impact a PICC-line has on patients’ body image were inconclusive.  It 
appeared that for some patients, the PICC-line represented a ‘badge’ of illness that they were 
unhappy to reveal whilst others had no such concerns.  As questionnaire data collection was 
conducted during the winter and spring, most participants had not experienced living with a 
PICC-line during the summer.  Therefore patients may have been less conscious of PICC-
line/pump visibility as it would have been camouflaged by winter clothing.  It is probable that 
more patients would have reported unease if data collection had taken place during warmer 
weather.   
   
Many participants needlessly perceived they must avoid crowded areas such as shopping 
centres for fear of the PICC-line being damaged, in keeping with Oakley et al’s study (2000).  
Given these patients had incurable cancer and did not have the promise of future health to 
look forward to, this is a concern as it could potentially lead to patients withdrawing from 
social situations they may have otherwise enjoyed. 
 
Study limitations 
The main limitation is that the study was conducted in only one setting.  All consecutive 
admissions during the data collection period were reviewed for study admission.  Arguably 
the sample is representative of our sampling frame; that is MdG patients receiving ambulatory 
chemotherapy in the oncology unit where data collection took place.  The questionnaire 
satisfied the conditions for content and face validity but nevertheless was designed 
specifically for this study and not subject to test-retest measurement. 
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Conclusions. 
The study explored the views and experiences of patients receiving ambulatory MdG 
chemotherapy via a PICC-line.  The results demonstrate that the majority held favourable 
views towards having a PICC-line and adapted well to the experience.  The main challenges 
centred on showering, bathing, hair washing and sleeping and worries continued during the 
treatment experience but there were others related to the provision of optimal information as 
there were some reports that information was unhelpful or scary.   
 
The value of this study was its ability to document specific difficulties faced by patients with 
PICC lines in the home environment in relation to a number of key areas and it is one of only 
a handful of studies which have examined the impact of a PICC line on ambulatory patients 
despite the huge increase in both the use of PICC lines and ambulatory chemotherapy.   
 
We would argue that although this was not a longitudinal study, it appeared that patients’ 
perceptions of problems with PICC-lines, lessened with time.  For example ‘time’ was 
mentioned frequently in interviews leading to the identified theme of 
“adaptation/acceptance”.  Questionnaire statements ‘having a PICC line gets easier the longer 
you have it’ and ‘patients with PICC lines need more help at the beginning’ had strong 
majority agreement.  Considering the interview findings with questionnaire responses, 
suggests that patients did find problems diminished with time as they adapted to having the 
PICC line in situ.   
 
In considering the implications of this study for future practice, we would recommend that (i) 
current information given to patients requiring a PICC-line should be reviewed locally and 
different methods of providing information explored; (ii) patients should be assessed formally 
as to their ability to cope at home with a PICC-line; (iii) ways of providing maximum support 
at the beginning of the PICC-line experience should be explored; (iv) PICC-lines should be 
considered for use in more chemotherapy patients; and finally (v) further research should be 
carried out into the specific needs of different groups of PICC-line patients. 
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Figure 1 Phase 1 data analysis thematic analysis steps 
 
Initial coding of 88 
keywords/significant 
statements    
Revised coding of 22 
broader categories   
Transcripts reread and 
accuracy of categories 
ensured    
Four themes reflecting 
interview content 
identified    
Transcripts considered 
alongside field notes 
and researcher’s 
thoughts   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Phase 2 patient profile 
 n (%) 
18 - 59 years 
60 - 79 years 
> 79 years 
 
20 (32.3%) 
39 (62.9%) 
3 (4.8%) 
Male 
Female 
 
34 (54.8%) 
28 (45.2%) 
< 20 miles from home to chemotherapy day unit 
> 20 miles from home to chemotherapy day unit 
 
34 (54.8%) 
28 (45.2%) 
Easy to get from home to chemotherapy day unit 
Difficult to get from home to chemotherapy day unit 
 
45 (72.6%) 
17 (27.4%) 
Knew what a PICC line was prior to insertion 
Didn’t know what a PICC line was prior to insertion 
Can’t remember 
 
5 (8.1%) 
49 (79%) 
8 (12.9%) 
1 PICC line required for this course of treatment 
2 PICC lines required for this course of treatment 
>2 PICC lines required for this course of treatment 
47 (75.8%) 
14 (22.6%) 
1 (1.6%) 
 1
 
Table 2 Phase 2 comparison of pre and post PICC line insertion daily life activity 
 
Daily life activity Number performing 
activity pre-PICC line 
insertion 
n=62 
Number reporting ‘a lot 
more difficulty’ post-
PICC line insertion  
n=62 
 
95% CI 
[for the population 
proportion experiencing ‘a 
lot more difficulty’ post-
PICC line insertion] 
 
Showering 44 25 (56.8%) (41%, 72%)* 
Washing hair  61 35 (57.3%) (44%, 70%)* 
Bathing 59 26 (44.0%) (30%, 58%)* 
Sleeping  62 17 (27.4%) (16%, 40%)* 
Shopping  62 9 (14.5%)  (7%, 26%) 
Dressing 62 8 (12.9%)  (5%, 24%) 
Hobbies 44 5 (11.4%)  (4%, 24%) 
Driving  41 4 (9.8%)  (3%, 23%) 
Washing myself 62 6 (9.7%)  (4%, 20%) 
Childcare 25 1 (4.0%) (0.1%, 20%) 
Cooking  54 4 (7.4%)  (2%, 18%) 
Housework 58 4 (6.9%)  (2%, 17%) 
Relaxing 60 2 (3.3%) (0.4%, 11%) 
* indicates activity is a ‘lot more difficult’ post-PICC line insertion 
 2
 Table 3 Differences in Phase 2 patients’ views on responsibility and coping at 
home with a PICC line  
 
Statement A/SA 
n=62 
D/SD 
n=62 
95% CI▲
 
There is plenty of help and support for people with PICC 
lines 
59 27 (83%, 100%) 
I worry about the chemotherapy spilling 
 
48 14 (33%, 76%) 
The PICC line has made my chemotherapy easier to get 
 
46 3 (55%, 83%) 
Having a PICC line gives me independence 
 
45 8 (42%, 78%) 
I am relaxed when I am at home with my PICC line 
 
45 11 (35%, 74%) 
I worry that things could go wrong with my PICC line 
 
42 20 (11%, 59%) 
I am happy to take responsibility for my PICC line* 
 
39 11 (26%, 66%) 
My family/friends worry about my PICC line* 
 
39 18 (11%, 58%) 
I worry that the PICC line will fall out 
 
38 22 (1%, 50%) 
PICC lines give me extra worries when getting 
chemotherapy 
 
18 39 (-56%, -11%) 
My life is restricted because of the PICC line 
 
12 41 (-67%, -26%) 
I would have preferred to get my chemotherapy in 
hospital 
 
4 52 (-91%, -63%) 
▲95% confidence intervals for population proportion of those who agree/strongly agree [A/SA] minus 
population proportion of those who disagree/strongly disagree [D/SD] for responsibility/coping statements. 
 
CIs in bold indicate a significant majority either agreeing (positive) or disagreeing (negative) with the 
statement. 
 
*missing data = 1 
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Table 4 Differences between MdG patients’ views on information giving   
 
Statement A/SA 
n=62 
D/SD 
n=62 
95% CI▲ 
 
I like to know as much as possible about what is 
happening to me 
 
47 11 (38%, 77%) 
It is impossible to remember all the information you are 
given 
 
47 14 (32%, 74%) 
I had all the information I needed to cope with my PICC 
line at home 
 
45 14 (29%, 71%) 
Some of the information I was given about my PICC line 
was quite scary 
 
43 17 (19%, 64%) 
The information I was given about my PICC line was just 
right 
 
42 8 (37%, 73%) 
I do not like to be told too much about things that could 
go wrong 
 
34 16 (7%, 50%) 
Too much information is a bad thing 
 
33 19 (0.03%, 45%) 
Doctors and nurses tell you things just because they feel 
they have to 
 
28 29 (-26%, 23%) 
Patients should be told absolutely everything about their 
PICC line 
 
26 28 (-27%, 20%) 
I knew what to expect when the PICC line was put in 
 
22 32 (-39%, 7%) 
I was given the choice to have a PICC line or not 
 
18 26 (-34%, 8%) 
 
▲95% confidence intervals for population proportion of those who agree/strongly agree [A/SA] minus 
population proportion of those who disagree/strongly disagree [D/SD] for responsibility/coping statements. 
 
CIs in bold indicate a significant majority either agreeing (positive) or disagreeing (negative) with the 
statement. 
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 Table 5 Differences between MdG patients’ views on adaptation/acceptance  
Statement A/SA 
n=62 
D/SD 
n=62 
95% CI▲
 
Having a PICC line gets easier the longer you have it  
 
52 7 (56%, 89%) 
The good things about a PICC line are more than the bad* 
 
50 0 (72%, 92%) 
I would recommend a PICC line to other patients** 
 
49 0 (72%, 92%) 
Patients with PICC lines need more help at the beginning 
 
44 7 (42%, 77%) 
I will do whatever it takes to get my chemotherapy 
 
43 15 (23%, 67%) 
I am frightened of needles 
 
40 21 (6%, 54%) 
I am happy to show my PICC line to anyone 
 
30 27 (-19%, 29%) 
It is best to avoid crowds if you have a PICC line 
 
29 21 (-9%, 35%) 
It bothers me if strangers see my PICC line 
 
23 34 (-42%, 6%) 
Having a PICC line in is a frightening experience 
 
17 38 (-56%, -11%) 
Having a PICC line is not the sort of thing you ever get 
used to 
 
14 43 (-68%, -25%) 
Having a PICC line is more trouble than it is worth* 
 
2 49 (-90%, -65%) 
 
▲95% confidence intervals for population proportion of those who agree/strongly agree [A/SA] minus 
population proportion of those who disagree/strongly disagree [D/SD] for responsibility/coping statements. 
 
CIs in bold indicate a significant majority either agreeing (positive) or disagreeing (negative) with the 
statement. 
 
*missing data = 1:  **missing data = 2 
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